Blueprint Bio was founded in 2015 to generate and transform intellectual property into commercial and social value, fulfilling the personalized medicine model. By identifying, protecting and offering new biological discoveries to existing clinical, pharmaceutical and diagnostic companies, Blueprint is creating a validated marketplace for biomarker signatures in personalized medicine.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/21/16 | $7,500,000 | Venture |
Forentis Partners | undisclosed |
